Nyxoah SA (NYXH): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
NYXH Stock Price Chart Interactive Chart >
NYXH Price/Volume Stats
| Current price | $29.13 | 52-week high | $37.00 |
| Prev. close | $29.40 | 52-week low | $23.15 |
| Day low | $29.10 | Volume | 1,300 |
| Day high | $30.31 | Avg. volume | 22,024 |
| 50-day MA | $31.87 | Dividend yield | N/A |
| 200-day MA | $0.00 | Market Cap | 726.59M |
Nyxoah SA (NYXH) Company Bio
Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.
Latest NYXH News From Around the Web
Below are the latest news stories about Nyxoah SA that investors may wish to consider to help them evaluate NYXH as an investment opportunity.
Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric CollapseINSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces U.S. FDA Breakthrough Device Designation Granted for the Genio® System for Obstructive Sleep Apnea and Complete Concentric Collapse Mont-Saint-Guibert (Belgium), September 14, 2021, 8:00 am CET / 2:00 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that |
Nyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare ConferenceNyxoah Announces Participation in the Cantor 2021 Virtual Global Healthcare Conference Mont-Saint-Guibert (Belgium), September 13, 2021, 10:30 pm CET / 4:30 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, will participate at the Cantor 2021 Global Healthcare Conf |
Information on the total number of voting rights and sharesREGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), September 12, 2021, 10:30 pm CET / 4:30 pm ET – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of 1,400,000 new warrants on September 8, 2021 and the issue of 82,500 new shares on September 10, 2021 pursuant to the exercise of subscription |
Nyxoah Announces Participation in the Baird 2021 Global Healthcare ConferencePRESS RELEASE Nyxoah Announces Participation in the Baird 2021 Global Healthcare Conference Mont-Saint-Guibert, Belgium – September 2, 2021, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that Olivier Taelman, Chief Executive Officer, and Fabian Suarez, Chief Financial Officer, will particip |
Publication relating to transparency notificationsPRESS RELEASE REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 1, 2021, 10.30pm CET / 4.30pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Robelga SRL / Robert Taub On August 27, 2021, Nyxoah received a transparency notification from Robelga SRL following the |
NYXH Price Returns
| 1-mo | -11.73% |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
| 2016 | N/A |
Loading social stream, please wait...